Amoy Diagnostics Co., Ltd.
Symboli: 300685.SZ
SHZ
20.6
CNYMarkkinahinta tänään
34.8241
P/E-suhde
0.0000
PEG-suhde
8.13B
MRK Cap
- 0.01%
DIV Tuotto
Amoy Diagnostics Co., Ltd. (300685-SZ) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 754 | 718.7 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 259.3 | 315.9 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 478.8 | 437.6 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 19.5 | 7.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 1285.1 | 1196 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 208.3 | 209.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -200.7 | -248.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 6.5 | 20.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 304.5 | 323.1 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 365.8 | 323.9 | ||||||||||||
balance-sheet.row.other-assets | 0 | 1946.5 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 1946.5 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 21.3 | 24 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 5.3 | 3.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 8.8 | 17.1 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 48.3 | 3 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 10.3 | 11.2 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 0 | 0.6 | 0.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 59.2 | 15 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.7 | 3 | ||||||||||||
balance-sheet.row.total-liab | 0 | 0 | 151.2 | 150.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 398.6 | 398.2 | 221.7 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 0 | 827.7 | 637.2 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 3.5 | 91.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1302.5 | 270.4 | 414.1 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1701.1 | 1499.7 | 1364.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 5.1 | ||||||||||||
balance-sheet.row.total-equity | 0 | 1701.1 | 1499.7 | 1369.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 0 | 58.6 | 67.6 | ||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 53.6 | 6.1 | ||||||||||||
balance-sheet.row.net-debt | 0 | 0 | -441 | -396.8 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 256.3 | 264.3 | 239 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 52.3 | 38.9 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | -13.7 | 1.1 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -58.9 | -125.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 25.9 | -132.3 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | -0.6 | -10.8 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | -98 | 19.2 | ||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -256.3 | -108.6 | 15.4 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 51.9 | 8.9 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -363.6 | -772.1 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 350.2 | 600.7 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.5 | -5.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -40.2 | -242.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.1 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 100.7 | 0 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -100.7 | -4.4 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -51.5 | -55.4 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -68 | 13.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -120.6 | -46.3 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 24.6 | -10 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 12.9 | -130.8 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 244 | 243.6 | 230.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 244 | 230.7 | 361.6 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 149 | 168.2 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 70.8 | 93.6 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1043.6 | 842.2 | 917 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 147.8 | 143.3 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 1043.6 | 694.4 | 773.8 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 748.4 | 524.3 | 508.9 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 748.4 | 672.1 | 652.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 6.1 | 3.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | -32.5 | 52.3 | 38.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 295.1 | 287.7 | 253.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 288.7 | 286.1 | 252 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 32.5 | 21.8 | 13 | ||||||||||||
income-statement-row.row.net-income | 0 | 256.3 | 263.7 | 239.6 |
Usein kysytty kysymys
Mikä on Amoy Diagnostics Co., Ltd. (300685.SZ) taseen loppusumma?
Amoy Diagnostics Co., Ltd. (300685.SZ) kokonaisvarat ovat 1946538300.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.889.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.444.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.246.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.283.
Mikä on Amoy Diagnostics Co., Ltd. (300685.SZ) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 256255700.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 0.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 748437800.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.